PREMO Study: to Investigate Port REMoval Outcomes (PREMO)
Pilot Trial to Assess Functional, Microbial, Radiological and Patient Reported Outcomes at Totally Implantable Venous Access Device (Port) Removal (PREMO Study)
Sponsor: B. Braun Medical SA
A NA clinical study on Cystic Fibrosis and Neoplasms, this trial is completed. The trial is conducted by B. Braun Medical SA and has accumulated 9 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
-
Aug 2019 — Jun 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
-
Jun 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- B. Braun Medical SA
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .